Susan Short, one of the researchers involved in this study, said that the team believes that Sativex may be the missing piece in the medical puzzle of treating glioblastoma. Short, who is the Professor of clinical oncology and neuro-oncology, claims that Sativex may be able to kill the tumor cells when it is given with the temozolomide chemotherapy treatment.
Michigan’s cannabis market is buzzing with excitement as we enter February 2025. Whether you’re searching…
California’s cannabis scene is thriving this February 2025, and we’re here to spotlight the best…
More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP),…
2025 is underway, Leafly nation! February is a month for momentum and risk, and we…
Advocacy groups are closely monitoring legislative developments and public sentiment, identifying specific states that are…
The researchers then analyzed the mood and emotional regulation capabilities of the participants during times…